Bluecrest Health Screening, a leading provider of affordable health checks, has secured a £17 million investment arranged by private equity firm Vespa Capital.
The private healthcare provider offers comprehensive health screening tests and has delivered results to over 250,000 customers across the largest network of mobile clinics in the UK and Ireland.
Bluecrest Health Screening offers unrivalled convenience and affordability compared with traditional high-priced health checks offered by private hospital groups.
The business has achieved rapid growth since its launch in 2012 and is now being used by over 350 employers, who are able to carry out health screenings for their workforce at their premises, promoting employee wellbeing and increasing productivity.
The deal supports the growth of Bluecrest Health Screening led by its co-founders, Peter Blencowe and Alex Higman and provides an exit for a number of individual seed investors, including Jim Lewcock of BLUE14.io Angel fund.
Peter Blencowe, Managing Director at Bluecrest Health Screening comments, “The support from private equity firm Vespa Capital is an endorsement of our vision to become the UK’s leading health screening provider.”
“Led by our strengthened board of directors, we’re looking forward to working together to deliver an ambitious five year growth plan, which will see digital services leveraged and a consolidation of our corporate proposition.”
“The business originally focussed on the consumer market and built a network of mobile clinics across the UK and Ireland. As the service has been extended into the corporate sector, more companies are benefiting from lower costs that enable them to offer health checks to a wider workforce. This has attracted industry recognition and in 2018 the business won two Workplace Savings and Benefits (WSB) awards for “Wellbeing Initiative of the Year” and “Best use of Technology for Benefits”.
“Bluecrest, with its proactive approach to healthcare, is ideally positioned to succeed in the changing landscape of the UK healthcare system,” comments Jim Lewcock of Blue14 Angel fund. “This investment, combined with new talent being brought into the team, will allow the business to harness the latest technologies and extend its market positioning.”
Of the partnership with Vespa Capital, Operations Director Alex Higman comments; “We’re delighted to be working with the Vespa Capital team. Bluecrest Health Screening is poised for continued significant growth and the partnership with Vespa Capital will serve to further consolidate the business through the next phase of development.”
Vendor advisory services were provided by Grant Thornton UK LLP.
For further information about Bluecrest Health Screening and its services please visit www.bluecrestscreening.com